View Screen Reader-Friendly Version

CRIT BIT CORNER

At the ready medical education

Insulin Autoimmune Syndrome

Insulin Autoimmune Syndrome (IAS) is a rare condition in which the body’s immune system produces antibodies that attach to insulin, leading to unpredictable blood sugar levels. These antibodies can temporarily block insulin’s action, causing high blood sugar, and later release insulin suddenly, resulting in severe hypoglycemia.

Etiology

Insulin Autoimmune Syndrome (IAS), also known as Hirata’s disease, is a rare cause of spontaneous hypoglycemia. IAS is characterized by recurrent spontaneous hypoglycemia, the presence of insulin antibodies in the body, and significantly elevated serum insulin [2].

Generally patients with IAS have no history of exogenous insulin injections, however, in recent years, it has been found that insulin and its analogs can also induce IAS [2].

It is defined by the development of antibodies against endogenous insulin, which bind circulating insulin and release it unpredictably, leading to fluctuations in glucose levels [2].

IAS is more commonly reported in East Asian populations, although increasing recognition has led to more global case identification [2].

Two Main Types of Syndromes

Insulin Autoimmune Syndrome (IAS)

  • Happens without insulin injections.
  • Often triggered by autoimmune diseases (e.g., SLE, Graves’ disease, rheumatoid arthritis) or certain medications like methimazole [2].
  • Most common in people of East Asian descent, but can happen in anyone [2].

Exogenous Insulin Antibody Syndrome (EIAS)

  • Happens in people who have been using insulin injections for diabetes.
  • The body starts making antibodies against injected insulin.
  • May occur after years of insulin therapy or shortly after starting insulin.

Both can result in a pattern of daytime high blood sugar (because insulin is blocked) and nighttime hypoglycemia (when the insulin is suddenly released) [3].

What Are Insulin Antibody Syndromes?

In most people with diabetes, insulin therapy helps lower blood sugar by moving glucose from the bloodstream into cells. But in rare cases, the immune system sees insulin as a threat and makes antibodies that attach to insulin.

These antibodies block insulin from doing its job or store it temporarily and release it later. This can cause unpredictable swings in blood sugar, including both very high and dangerously low levels.

What Affects the Risk of Developing Insulin Antibodies?

Type of Insulin Matters

Animal insulin (from cows or pigs):

  • Looks different to the human body [4].
  • More likely to trigger an immune response (higher chance of antibodies forming) [4].

Recombinant human insulin (lab-made insulin that mimics human insulin):

  • Matches natural human insulin exactly [4].
  • Still can cause antibodies, but it's less likely than animal insulin [4].

Insulin analogues (modified versions of human insulin):

  • Designed to work faster or slower in the body (e.g., lispro, glargine) [4].
  • Have small changes in their structure [4].
  • These changes can affect how the immune system responds [4].

Bottom line: Even though modern insulins are safer, any insulin can still cause antibodies in rare cases, especially in people with autoimmune conditions [4].

What Causes the Body to React This Way?

Genetics

  • Some people are more likely to form insulin antibodies.

Autoimmune diseases

  • Conditions like Graves’ disease or lupus are often linked [2].

Medication triggers

  • Methimazole (used for hyperthyroidism) is a known culprit in IAS [3].

Insulin types

  • Older animal-based insulin used to cause this more often, but even modern synthetic insulin (like glargine or aspart) can cause antibody reactions in rare cases [4].

Delivery method

  • Continuous insulin pumps or certain injection sites may make the immune system more reactive [4].

What Happens Inside the Body?

There are two main ways insulin antibodies interfere with blood sugar control:

Tampon-like effect

  • The antibodies soak up insulin, blocking it from lowering blood sugar. This leads to high glucose, especially after meals [4].

Reservoir-like effect

  • Later on—especially at night—the insulin is released from the antibodies all at once, causing unexpected hypoglycemia [4].

This results in chaotic blood sugar patterns that don’t respond to normal insulin adjustments.

Signs You Might Notice

Blood Sugar Fluctuations in Insulin Antibody Syndrome (EIAS)

The main symptom of IAS is wild swings in blood sugar throughout the day.

Most patients experience:

  • High blood sugar during the day (especially after meals) [4].
  • Low blood sugar at night (often unexpected or severe) [4].

Why does this happen?

  • Insulin antibodies grab onto insulin after it's injected→ Antibody “tampon” effect [4].
  • This blocks insulin from working right away, leading to high sugar after eating (called postprandial hyperglycemia) which may require careful administration of insulin [1].
  • Later, especially at night, the insulin is suddenly released, causing blood sugar to crash → Antibody “reservoir” effect [4].

Reversible Process

  • The body’s pH (acid/base balance) changes throughout the day.
  • At night, this change triggers insulin to break free from the antibodies → causing low blood sugar [4].

How Is It Diagnosed?

Insulin antibody levels

  • Elevated if the syndrome is present [2].

C-peptide levels

  • Help show whether the body is making its own insulin. May also help rule out other causes such as insulinoma [2].

Glucose logs

  • Wide swings without a clear cause are a big clue [2].

Imaging (like CT or MRI)

  • May be done to rule out insulinoma, a rare tumor that causes hypoglycemia [2].

Treatment Options

There’s no simple fix, but the following treatments may help:

Change the type of insulin

  • Some patients respond better to different insulin types (e.g., lispro or glulisine).
  • Sometimes switching to shorter-acting insulins reduces antibody binding [3].

Steroids (like prednisone)

  • Glucocorticoids (e.g., methylprednisolone or prednisone) to suppress antibody production [3]

Supportive meds and diet

Acarbose

  • Acarbose can slow down sugar absorption from food.
  • Anti-diabetic medication that lowers your blood sugar by preventing the breakdown of starch into sugar [5].

Cornstarch

  • Bedtime snacks containing cornstarch can help stabilize overnight blood glucose levels.
  • Cornstarch is a complex carbohydrate that is slowly digested and absorbed, leading to a gradual release of glucose into the bloodstream.
  • This slow release helps prevent sharp spikes after eating and reduces the risk of fasting hypoglycemia during the night [1].

Plasmapheresis (Therapeutic Plasma Exchange - TPE)

  • Used in refractory or severe cases to remove antibodies
  • Led to rapid clinical improvement, with glucose stabilization and antibody reduction [1]
  • Mechanism: removal of circulating insulin-antibody complexes [1]

Plasmapheresis Mechanism Explained

Removes harmful insulin autoantibodies (IAs)

  • These antibodies are causing all the blood sugar swings.
  • TPE filters the patient’s plasma (the liquid part of blood) and replaces it with clean fluid like albumin.
  • This reduces the number of insulin-binding antibodies [1].

Reduces insulin-antibody complexes

  • With fewer antibodies, more insulin stays free and active, working properly [1].
  • That means less risk of random highs or lows in blood sugar.

Leads to lower insulin needs

  • Their blood sugars also became more stable, with fewer extreme highs or lows [1].

Nursing considerations during plasmapheresis

  • Watch for hypotension, coagulopathy, hypocalcemia [1].
  • Coordinate anticoagulation and replacement fluids with the apheresis team [1].

Prognosis

Most cases resolve within months after removal of the trigger and initiation of immunosuppressive therapy [3]

TPE offers rapid relief when steroid therapy is insufficient or too slow [1]

Long-term outcomes are favorable if managed early [2]

Case Study

Chief Complaint

A 19-year-old Female with type 1 diabetes mellitus (T1DM) presented with diabetic ketoacidosis (DKA). After initial stabilization, she developed persistent and severe hypoglycemia, raising concern for insulin autoimmune syndrome (IAS).

Relevant Medical History

  • T1DM (since age 4)
  • Graves’ disease (recently switched from methimazole—a known IAS trigger—to propylthiouracil)
  • Celiac disease
  • Partial adrenal insufficiency
  • ADHD, anxiety, depression

Clinical Course

Following DKA treatment, the patient exhibited extreme glucose variability (blood glucose 28–620 mg/dL), requiring:

  • Multiple D50 boluses
  • Continuous D10% IV infusion
  • Maximal insulin titration with minimal effect

Insulin antibody level: 0.2 nmol/L (normal <0.02) → diagnostic for IAS

Treatment

Initial management with prednisone 40 mg daily, but hypoglycemia persisted. The endocrinology team initiated therapeutic plasma exchange (TPE):

TPE Details

  • Initial plan: 3 sessions
  • Revised plan: 7 sessions, based on literature suggesting better outcomes with 4–7 treatments
  • Replacement fluid: 2500 mL albumin
  • Response: Improved glucose stability and reduced insulin needs

Vital Signs and Monitoring

  • Heart rate: 91–109 bpm
  • Respiratory rate: 18–24 breaths/min
  • SpO₂: 97–99% on room air
  • Blood glucose: Fluctuated widely despite continuous management

Assessment

This patient’s presentation of refractory hypoglycemia, positive insulin antibodies, and autoimmune comorbidities strongly supports a diagnosis of IAS. The case was complicated by poor response to steroids alone. Pt is currently receiving TPE with hopes for marked improvement in blood glucose stability.

Plan

  • Complete 7 planned TPE sessions
  • Reassess insulin antibody titers post-TPE
  • Maintain frequent glucose monitoring
  • Continue nutritional support
  • Coordinate long-term care with Endocrinology and Hematology

Discussion

Insulin Autoimmune Syndrome (IAS) is a rare, immune-mediated cause of hypoglycemia, often linked to autoimmune conditions such as Graves’ disease and Celiac disease—both present in this patient. Her risk was further heightened by recent exposure to methimazole, a medication known to trigger IAS. Although IAS can occur in individuals with or without prior insulin use, this patient had been receiving exogenous insulin. When symptoms persist despite steroid therapy, the decision was made to utilize therapeutic plasma exchange (TPE) as an effective second-line treatment that works by removing circulating insulin-antibody complexes.

References

  1. Zhuang Y, Wei X, Yu Y, Wang D. Exogenous insulin antibody syndrome treated with plasma exchange after an incomplete response to immunosuppressive therapy. J Clin Apher. 2021;36(4):664–667. doi:10.1002/jca.21905
  2. Lin MX, Chen YH, Ning J. Insulin Autoimmune Syndrome: A Systematic Review. Int J Endocrinol. 2023;2023:1225676. doi:10.1155/2023/1225676​
  3. Censi S, Mian C, Betterle C. Insulin autoimmune syndrome: from diagnosis to clinical management. Ann Transl Med. 2018;6(17):335. doi:10.21037/atm.2018.07.32
  4. Hu X, Chen F. Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients. Endocr Connect. 2018;7(1):R47–R55. doi:10.1530/EC-17-0309
  5. Mayo Clinic. Acarbose (Oral Route). [Internet]. Rochester (MN): Mayo Foundation for Medical Education and Research; c2024 [cited 2025 Mar 25]. Available from: https://www.mayoclinic.org/drugs-supplements/acarbose-oral-route/description/drg-20067949.

Disclaimer: these crit bits are intended to spark curiosity and sharpen critical thinking. They are not a substitute for UpToDate, institutional guidelines, or provider orders. 

CREATED BY
At The Ready Medical Education

Credits:

Created with images by peshkova - "Man's hands working with notes background. Modern computer record diagram with virtual mnitor." • Minerva Studio - "Diabetes concept" • Sherry Young - "Human Insulin Vials" • SR07XC3 - "Microscopic Imaging of Insulin-Producing Pancreatic Cells in Diabetes Management" • Sherry Young - "Diabetes" • Proxima Studio - "Doctor checking blood sugar level with glucometer" • gamjai - "Sample blood for screening diabetic test." • Sherry Young - "Insulin And Syringe" • thanksforbuying - "Blood glucose meter, lancet and stethoscope on blue background, diabetes concept" • sdecoret - "Doctor using digital medical futuristic interface 3D rendering"